HIV and HCV risk reduction interventions in drug detoxification and treatment settings.

This presentation, part of a symposium at the CPDD meeting entitled, “Primary Findings from HIV/AIDS Research in the NIDA Clinical Trials Network” (chaired by Donald A. Calsyn), describes protocol CTN-0017, “HIV and HCV Intervention in Drug Treatment Settings.” This study aimed to reduce injection-related HIV and HCV risk behaviors, while also increasing treatment entry and retention.

Three interventions were compared: NIDA Counseling & Education Intervention (C&E), which offers HIV & HCV education and protective skills training and encouragement; Therapeutic Alliance Intervention (TA), which uses a single session with an outpatient counselor to identify treatment goals, tasks, and expectations; and Treatment as Usual (TAU), which includes typical clinic procedures such as risk reduction education and referral for HIV testing and continuing care. The presentation ends with an analysis of the “outcomes so far.”

Related protocols: CTN-0017